H, L., & A, Z. (2020). ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis. Annals of surgical oncology, 27(10), 3961. https://doi.org/10.1245/s10434-020-08542-2
Chicago Style (17th ed.) CitationH, Liu, and Zureikat A. "ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis." Annals of Surgical Oncology 27, no. 10 (2020): 3961. https://doi.org/10.1245/s10434-020-08542-2.
MLA (9th ed.) CitationH, Liu, and Zureikat A. "ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis." Annals of Surgical Oncology, vol. 27, no. 10, 2020, p. 3961, https://doi.org/10.1245/s10434-020-08542-2.